Friday Blog Roundup

There’s been a lot of blogging about vaccines lately:

Elsewhere:

Emily Monosson at The Neighborhood Toxicologist investigates EPA’s decisions about nanotechnology regulation.

David Roberts at Gristmill looks at the big stories emerging from the League of Conservation Voters’ just-released scorecard.

Roy M. Poses MD at Health Care Renewal delves into the torturous supply chain and inadequate oversight of Baxter’s heparin.

Maggie Mahar at Health Beat wonders where the doctors were during the “Cholesterol Con” that’s now coming to light.

Merrill Goozner at GoozNews suggests a different approach that FDA could use regarding the approval of Avastin for breast cancer.

Lisa Codipoti at Womenstake uses a personal example to illustrate one of the problems with primary care in our current system.

Michael Kremer at Global Health Policy explains why mass treatment through schools is an effective use of the funds President Bush has pledged to invest in fighting neglected tropical diseases.

Comments

  1. #1 Abel Pharmboy
    February 23, 2008

    Thanks, Liz! I’m never one to pass up a personal event as a learning opportunity for promoting public health and medical education!

  2. #2 arbiter of waste
    February 29, 2008

    Great post, and I think the Chinese will do nothing that sounds remotely threatening to the Western companies producing drugs/food in China. And the FDA will continue to merely issue warnings and do nothing. Hard to be optimistic when your president is so partial to industry and indifferent to consumers.